OTC Healthcare in Israel
Euromonitor International's OTC Healthcare in Israel market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 93 | Publication date: Jun 2006
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; Vitamins and dietary supplements; Wound treatments
Executive summary
Overall recovery of the Israeli market
2005 was significant for the overall Israeli economy and particularly for the OTC healthcare market. The growth rates were influenced by the general recovery of the Israeli economy during 2005 as well as the affect of OTC Healthcare reform, which was carried out in May 2005. The most successful sector was vitamins and dietary supplements, which remained the market's leading sector. Analgesics followed in second place in terms of size and recorded third greatest growth in 2005. New products, especially those that were child-specific, as well as new packages and marketing efforts also contributed to the success of the OTC healthcare market in 2005.
Market does not adjust to the new regulations as expected
The new regulations that allow OTC healthcare products to be purchased in outlets other than pharmacies were brought into effect in May 2005. The market did not respond as expected and few OTC healthcare products were approved to be sold in outlets other than pharmacies. Even after the few approvals that did take place, supermarkets and fuel stations did not offer the de-regulated products, and they continued to mainly be sold over the counter in drugstores.
However, the influence of the regulations is expected to transform the market in the first few years of the forecast period, with the result that more OTC healthcare products will be available in outlets other than pharmacies.
Herbal products lose popularity level
During the last few years of the review period, there was a growing trend for the use of herbal products. In 2005, this trend started to wane as there was a lower demand for herbal products. This decrease in growth was mostly associated with the fact that herbal products are less effective than standard ones. The effectiveness of herbal products was widely discussed in the media in 2005 and this had a negative affect on public opinion towards these remedies.
Child-specific sectors will continue growth and increased popularity
Overall growth of child-specific products will be driven by increased consumer and health professional awareness that will stimulate demand. At the end of the review period, most child-specific products were a version of products that already existed in the market, but in a form suitable for children. Sales will continue to grow as this pattern is expected to increase over the forecast period.
Higher growth rates are expected in forecast period
Forecasts for the Israeli economy are always subject to the political situation. The business environment is strongly affected by the political atmosphere. At the end of the review period the forecast period was uncertain due to the impending 2006 elections in both the Israel and the Palestinian authority. It is hoped that the positive economic growth of the review period will continue in the forecast period when the new regulations will be taken more seriously by retailers and companies alike. Drugstores are expected to expand at the expense of traditional pharmacies.
Table of contents
OTC HEALTHCARE IN ISRAEL : MARKET INSIGHT
EXECUTIVE SUMMARY
OPERATING ENVIRONMENT
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Advertising
Packaging and Labelling
Distribution
De-listing or De-reimbursement
Traditional Remedies
Homeopathy
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
Life Expectancy
Table 2 Life Expectancy at Birth 2000-2005
OTC HEALTHCARE SALES
Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 2000-2005
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
Switches
Table 5 OTC Healthcare Approval to be Sold in Outlets Other than Pharmacies 2005
Competitive Environment
Table 6 OTC Healthcare Company Shares by Retail Value 2001-2005
Table 7 OTC Healthcare Brand Shares by Retail Value 2002-2005
Retail Distribution
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
Retailer Activity and Private Label Trends
Table 10 Penetration of Private Label by Sector 2001-2005
Forecast Market Performance
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2005-2010
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
DEFINITIONS
LOCAL COMPANY PROFILES - ISRAEL
HADAS NATURAL PRODUCTS - OTC HEALTHCARE - ISRAEL
COMPANY BACKGROUND
RECENT NEWS
Summary 1 Summary - Hadas Natural Products: Operational Indicators 2005
PRODUCTION CAPACITY
REKAH PHARMACEUTICAL PRODUCTS LTD - OTC HEALTHCARE - ISRAEL
COMPANY BACKGROUND
RECENT NEWS
Summary 2 Summary - Rekah Pharmaceutical Products Ltd: Operational Indicators 2005
PRODUCTION CAPACITY
TARO PHARMACEUTICAL INDUSTRIES LTD - OTC HEALTHCARE - ISRAEL
COMPANY BACKGROUND
RECENT NEWS
Summary 3 Summary - Taro Pharmaceutical Industries Ltd: Operational Indicators 2004
PRODUCTION CAPACITY
TEVA PHARMACEUTICAL INDUSTRIES LTD - OTC HEALTHCARE - ISRAEL
COMPANY BACKGROUND
RECENT NEWS
Summary 4 Summary - Teva Pharmaceutical Industries Ltd: Operational Indicators 2004
PRODUCTION CAPACITY
KEY FACTORS FOR FORECAST PERIOD ANALYSIS
ANALGESICS IN ISRAEL
SECTOR PERFORMANCE
2005 headlines
Higher growth rate – first sign of influence of new regulations
Analgesics was first to be approved as a result of new regulations
Analgesics bought by 45% of Israelis
Table 13 Frequency of Analgesics Use
Teva Pharmaceutical Industries Ltd dominates the sector
Adult analgesics
Child-specific analgesics
Topical analgesics
Forecast performance
Table 14 Sales of Analgesics by Subsector: Value 2000-2005
Table 15 Sales of Analgesics by Subsector: % Value Growth 2000-2005
Table 16 Analgesics Company Shares by Retail Value 2001-2005
Table 17 Analgesics Brand Shares by Retail Value 2002-2005
Summary 5 Summary - Analgesics: New Product Launches 2004-2005
Table 18 Forecast Sales of Analgesics by Subsector: Value 2005-2010
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2005-2010
TOPICAL ANALGESICS BY HERBAL/STANDARD SPLIT
Table 20 Herbal vs Standard Topical Analgesics 2000/2005
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ISRAEL
SECTOR PERFORMANCE
2005 headlines
Growth rate remained stable
Israel's climate and high population density increase prevalence of seasonal illness
Israeli prefer combined solutions – Dexamol cold
Forecast performance
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2000-2005
Table 22 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2000-2005
Table 23 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2001-2005
Table 24 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2002-2005
Summary 6 Summary - Cough, Cold and Allergy (Hay Fever) Remedies: New Product Launches 2004-2005
Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2005-2010
Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2005-2010
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES BY HERBAL/STANDARD SPLIT
Table 27 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2000/2005
DECONGESTANTS PERFORMANCE
Good year for decongestants with 9% growth
Table 28 Sales of Decongestants by Type: Value 2000-2005
Table 29 Sales of Decongestants by Type: % Value Growth 2000-2005
CHILD-SPECIFIC COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES PERFORMANCE
Child-specific cough and cold remained leading the subsector
Syrup vs. candy-like medicines
Table 30 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2000-2005
Table 31 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2000-2005
DIGESTIVE REMEDIES IN ISRAEL
SECTOR PERFORMANCE
2005 headlines
Growth course continues due to stressful routine
Laxatives still dominates the sector
New laxatives by Novartis
Forecast performance
Table 32 Sales of Digestive Remedies by Subsector: Value 2000-2005
Table 33 Sales of Digestive Remedies by Subsector: % Value Growth 2000-2005
Table 34 Digestive Remedies Company Shares by Retail Value 2001-2005
Table 35 Digestive Remedies Brand Shares by Retail Value 2002-2005
Summary 7 Summary - Digestive Remedies: New Product Launches 2004-2005
Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2005-2010
Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2005-2010
DIGESTIVE REMEDIES BY HERBAL/STANDARD SPLIT
Table 38 Herbal vs Standard Digestive Remedies 2000/2005
OTHER INDIGESTION AND HEARTBURN REMEDIES PERFORMANCE
CHILD-SPECIFIC DIGESTIVE REMEDIES
Table 39 Sales of Other Indigestion and Heartburn Remedies by Type: Value 2000-2005
Table 40 Sales of Other Indigestion and Heartburn Remedies by Type: % Value Growth 2000-2005
MEDICATED SKIN CARE IN ISRAEL
SECTOR PERFORMANCE
2005 headlines
Maintaining stable growth since 2002
Leading product of vaginal antifungals increases share
Further growth for topical allergy remedies
Forecast performance
Table 41 Sales of Medicated Skin Care by Subsector: Value 2000-2005
Table 42 Sales of Medicated Skin Care by Subsector: % Value Growth 2000-2005
Table 43 Medicated Skin Care Company Shares by Retail Value 2001-2005
Table 44 Medicated Skin Care Brand Shares by Retail Value 2002-2005
Summary 8 Summary - Medicated Skin Care: New Product Launches 2004-2005
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2005-2010
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2005-2010
MEDICATED SKIN CARE BY HERBAL/STANDARD SPLIT
A decrease in demand for herbal products
An increase in demand for herbal products in medicated shampoos subsector
Table 47 Herbal vs Standard Medicated Skin Care 2000/2005
ACNE TREATMENTS BRAND SHARES
High growth rate due to growing awareness
Forecast performance
Table 48 Acne Treatments Brand Shares by Retail Value 2002-2005
HAIR LOSS TREATMENTS BRAND SHARES
Regaine at the top
Treatments for men vs women
Table 49 Hair Loss Treatments Brand Shares by Retail Value 2002-2005
VITAMINS AND DIETARY SUPPLEMENTS IN ISRAEL
SECTOR PERFORMANCE
2005 headlines
Vitamins and dietary supplements remain leading OTC healthcare sector
Ma'abrot's control over Ta'am Teva Pharmaceutical Industries Ltd and Altman
Child-specific offers a wider variety of products
Forecast performance
Table 50 Sales of Vitamins and Dietary Supplements by Subsector: Value 2000-2005
Table 51 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2000-2005
Table 52 Vitamins and Dietary Supplements Company Shares by Retail Value 2001-2005
Table 53 Vitamins and Dietary Supplements Brand Shares by Retail Value 2002-2005
Summary 9 Summary - Vitamins and Dietary Supplements: New Product Launches 2004-2005
Table 54 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2005-2010
Table 55 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2005-2010
VITAMINS PERFORMANCE
High growth rate of vitamin B subsector
Ambrosia Ltd Solgar dominates both multivitamins and single vitamins
Table 56 Sales of Vitamins by Type: Value 2000-2005
Table 57 Sales of Vitamins by Type: % Value Growth 2000-2005
Table 58 Vitamins Brand Shares by Retail Value 2002-2005
DIETARY SUPPLEMENTS PERFORMANCE
Great growth rate during 2005
Chizukit by Hadas Natural Products remained leading product
Calcium supplements doubled its sales during 2005
Table 59 Sales of Dietary Supplements by Type: Value 2000-2005
Table 60 Sales of Dietary Supplements by Type: % Value Growth 2000-2005
Table 61 Dietary Supplements Brand Shares by Retail Value 2002-2005
Table 62 Dietary Supplements by Positioning: % Retail Value Analysis 2005
NRT SMOKING CESSATION AIDS IN ISRAEL
NUMBER OF SMOKERS
Table 63
SECTOR PERFORMANCE
2005 headlines
High growth trend since 2003
Higher awareness and smoking cessation campaigns
Forecast performance
Table 64 Sales of NRT Smoking Cessation Aids by Subsector: Value 2000-2005
Table 65 Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2000-2005
Table 66 NRT Smoking Cessation Aids Company Shares by Retail Value 2001-2005
Table 67 NRT Smoking Cessation Aids Brand Shares by Retail Value 2002-2005
Table 68 Forecast Sales of NRT Smoking Cessation Aids by Subsector: Value 2005-2010
Table 69 Forecast Sales of NRT Smoking Cessation Aids by Subsector: % Value Growth 2005-2010
EYE CARE IN ISRAEL
SECTOR PERFORMANCE
2005 headlines
Stable growth in 2005, contrary to expectations following market reform
Stilla and Visine remained the leaders
Forecast performance
Table 70 Sales of Eye Care by Subsector: Value 2000-2005
Table 71 Sales of Eye Care by Subsector: % Value Growth 2000-2005
Table 72 Eye Care Company Shares by Retail Value 2001-2005
Table 73 Eye Care Brand Shares by Retail Value 2002-2005
Table 74 Forecast Sales of Eye Care by Subsector: Value 2005-2010
Table 75 Forecast Sales of Eye Care by Subsector: % Value Growth 2005-2010
EAR CARE IN ISRAEL
SECTOR PERFORMANCE
Summary 10 Summary - Ear Care: New Product Launches 2004-2005
ADULT MOUTHCARE IN ISRAEL
SECTOR PERFORMANCE
Summary 11 Summary - Adult Mouthcare: New Product Launches 2004-2005
CALMING AND SLEEPING PRODUCTS IN ISRAEL
SECTOR PERFORMANCE
Summary 12 Summary - Calming and Sleeping Products: New Product Launches 2004-2005
WOUND TREATMENTS IN ISRAEL
SECTOR PERFORMANCE
2005 headlines
Relatively minor reaction to the new market regulations
Polydin ointment by Dr Fischer dominates sticking plasters subsector
Forecast performance
Table 76 Sales of Wound Treatments by Subsector: Value 2000-2005
Table 77 Sales of Wound Treatments by Subsector: % Value Growth 2000-2005
Table 78 Wound Treatments Company Shares by Retail Value 2001-2005
Table 79 Wound Treatments Brand Shares by Retail Value 2002-2005
Table 80 Forecast Sales of Wound Treatments by Subsector: Value 2005-2010
Table 81 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2005-2010
EMERGENCY CONTRACEPTION IN ISRAEL
SECTOR PERFORMANCE